» Articles » PMID: 31047701

How to Perform and Report a Cardiopulmonary Exercise Test in Patients with Chronic Heart Failure

Overview
Journal Int J Cardiol
Publisher Elsevier
Date 2019 May 4
PMID 31047701
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

In the present practice review, we will explain how to perform and interpret a cardiopulmonary exercise test (CPET) in heart failure patients. Specifically, we will explain why cycle ergometer should be preferred to treadmill, the type of protocol needed, and the ideal exercise duration. Thereafter, we will discuss how to interpret CPET findings and determine the parameters that should be included. We will focus specifically on: peak VO (absolute value and a percentage of its predicted value), exercise duration, respiratory exchange ratio, peak work rate, heart rate, O pulse, end-tidal carbon dioxide pressure (PetCO), PetO, and -if blood gas samples are obtained-dead space to tidal volume ratio. Moreover, we will discuss the physiological and clinical value of anaerobic threshold, respiratory compensation point, ventilation vs. VCO and VO vs. work relationships. Finally, attention will be dedicated to exercise-induced periodic breathing. We will also discuss when and why CPET should be integrated with other measurements in the so-called complex CPET. Specifically: a) when and how to use a complex non-invasive CPET, which integrates CPET measurements with non-invasive cardiac output determination, working muscle near-infrared spectroscopy, transthoracic echocardiography, thoracic ultrasound, and lung diffusion analysis; b) when and how to use a complex minimally invasive CPET, in which CPET is combined with esophageal balloon recordings or with serial arterial blood sampling for blood gas analysis; c) when and how to use a complex invasive CPET, which usually implies the presence of a Swan Ganz catheter in the pulmonary artery and an arterial line.

Citing Articles

Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with non-reduced ejection fraction.

Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.

PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.


Prognostic Value of Submaximal Cardiopulmonary Exercise Testing in Patients With Cardiac Amyloidosis.

Willixhofer R, Ermolaev N, Kronberger C, Eslami M, Vilsmeier J, Rettl R Circ Rep. 2025; 7(2):76-85.

PMID: 39931706 PMC: 11807689. DOI: 10.1253/circrep.CR-24-0152.


Cardiopulmonary Exercise Testing: Methodology, Interpretation, and Role in Exercise Prescription for Cardiac Rehabilitation.

Kabbadj K, Taiek N, El Hjouji W, El Karrouti O, El Hangouche A US Cardiol. 2025; 18():e22.

PMID: 39872828 PMC: 11770537. DOI: 10.15420/usc.2024.37.


Cardiopulmonary Exercise Testing: Deciphering Cardiovascular Complications in Systemic Sclerosis.

Giubertoni A, Bellan M, Cumitini L, Patti G Rev Cardiovasc Med. 2025; 26(1):25914.

PMID: 39867169 PMC: 11759969. DOI: 10.31083/RCM25914.


Oxygen uptake efficiency slope at anaerobic threshold can predict peak VO in adult congenital heart disease.

FitzMaurice T, Hawkes S, Liao Y, Cullington D, Bryan A, Redfern J Int J Cardiol Congenit Heart Dis. 2024; 18:100546.

PMID: 39713225 PMC: 11658284. DOI: 10.1016/j.ijcchd.2024.100546.